Tonix in the News :: Tonix Pharmaceuticals Holding Corp. (TNXP)

Proactive | May 25, 2022

Tonix Pharmaceuticals Talks Through its 1Q 2022 Financial and Operational Highlights

Benzinga | May 5, 2022

At Tonix, History Underpins a Modern Approach to COVID-19 Vaccines

Bloomberg | May 2, 2022

Balance of Power: Omicron Subvariant Raises Concerns (Podcast)

Benzinga | Apr 7, 2022

Tonix Pharma Starts New Pivotal Trial For TNX-102 SL In Fibromyalgia Patients

FiercePharma | Mar 8, 2022

Mass General plans study of nasally delivered binge eating disorder drug

Clinical Trials Arena | Feb 8, 2022

Long Covid-19: Tonix reveals Phase II trial design plans

Benzinga | Feb 1, 2022

Could This Be A Potential New Weapon In The Fight Against COVID-19?

HCP Live | Nov 6, 2021

Daily Sublingual Cyclobenzaprine Improves Sleep, Pain Outcomes in Fibromyalgia Patients

Maryland.gov | Oct 20, 2021

Tonix Pharmaceuticals expands into Frederick, Md.

The Frederick News-Post | Oct 18, 2021

New Infectious Disease Research and Development Center Opens in Frederick